SHANGHAI, Jan. 16, 2012 /PRNewswire-Asia/ -- BioChina International 2012 will be held on June 26th-27th, at the Jin Jiang Oriental Hotel Shanghai, China.
On the way to achieving antibody industrialization, China is faced with challenges in transforming good research into effective products that can be reproduced in large quantities and meet all regulatory and quality standards. The key to overcoming the above challenges lies in bioprocessing. Advancements on scale-up, pilot production, purification, expression technologies and quality control, etc., are some key issues that the industry stakeholders need to take into consideration when working on strategies to bring China's biopharma industry into the next level. Apart from challenges in bioprocess technologies, China is working towards better biosimilar and antibody R&D to fill limited product pipelines. With patent cliff for most of the biologics in 2015, biosimilar has been recognized as a great opportunity and a major trend for the future of the biopharma industry.
Riding on the booming biopharma industry in China, the inaugural BioChina International Conference 2012 is positioned to be the largest biopharma conference in China to focus on the latest bioprocess and antibody advancement in China and globally. The content rich conference aims to build a definitive platform for biopharma industry leaders to gain proven strategies and solutions to finding new targets, optimizing epitope design for monoclonal antibodies, scaling both upstream and downstream processes, building pilot plants, advancing cell line development, improving quality and ensuring comparability of mAbs, biosimilars, biobetters and vaccines.
About Shine Media
Shine Media is a progressive business media, serving clients from around the world. We offer a comprehensive product mix, ranging from summits, business to business congresses, and tradeshows to made-on-demand specialty seminars. By bringing business communities together, in person, in print or online, we help decision-makers get ahead of the curve on emerging issues, make key connections, and reach out to new customers. Shine Media International, previously Global Leaders Institute, owns other featured events, including the "Asia Pharma R&D Leaders" and "VacChina International" conference series.
|SOURCE Shine Media International Ltd.|
Copyright©2010 PR Newswire.
All rights reserved